We have examined the influence of taxol and cisplatin on the rate and extent of proliferation of T47D cells grown in the presence of 5% fetal bovine serum (FBS). An 8-day exposure of the cells to taxol inhibited the growth completely maintaining the number of cells to the level seen at initial plating. The taxol effect was evident at 10 nM -1 concentration and the half maximum inhibition was calculated to be 20 nM taxol. While the cells in the control group continued to proliferate during the 8-day growth period, cells in the taxol-treated group remained at the initial number. Similar observations were made regarding the influence of cisplatin, which caused 80-90% inhibition in the number of the cells. When combined, taxol and cisplatin caused a further inhibition in the proliferation of T47D cells. The results of our studies demonstrate that both taxol and cisplatin, the known antineoplastic agents, block the proliferation of T47D human breast cancer cells effectively and are potentially useful chemotherapeutic agents for the management of breast cancer. Taxol works as a mitotic spindle toxin which promotes formation of stabilized dysfunctional microtubules by accelerating the rate of assembly but disallows depolymerization of microtubules (4). It has also been reported that taxol effects are phase-specific as it is more toxic to mitotic cells than interphase cells (5). While the effects of taxol have been studied on mitotic behavior of several cancer cell lines, it has been reported that mammalian cell lines respond differentially To whom correspondence and requests for reprints should be addressed
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1994 Academic pass, Inc. Taxol is gaining much attention as one of the more effective anticancer chemotherapeutic agents (1) . Initially isolated from the bark of the pacific yew, Taxus brevifolia (Reviewed in Ref. 2) , successful chemical synthesis of taxol has been recently accomplished (3) . What makes taxol an interesting antitumor compound is the relative success gained in delineating its mode of action.
Taxol works as a mitotic spindle toxin which promotes formation of stabilized dysfunctional microtubules by accelerating the rate of assembly but disallows depolymerization of microtubules (4) . It has also been reported that taxol effects are phase-specific as it is more toxic to mitotic cells than interphase cells (5) . While the effects of taxol have been studied on mitotic behavior of several cancer cell lines, it has been reported that mammalian cell lines respond differentially To whom correspondence and requests for reprints should be addressed at Department of Biol. Sci., Oakland University, Rochester, MI 48309-4401. Vol. 202, No. 3, 1994 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS in their ability to enter cell cycle when challenged by agents which disrupt microtubule polymerization (6).
Cisplatin, cis-dichlorodiammineplatinum (II), has been known to exert wide cellular responses and antitumor activity against several malignancies including cancers of the lungs, ovaries, testes, bladder, esophagus, head and neck. The cellular actions of cisplatin are believed to be due to the formation of DNA adducts, which blocks the cell growth in the G2 phase causing the cell death by apoptosis (7) . Because of the effectiveness of the platinum compounds as antitumor agents, a combination chemotherapy involving cisplatin and taxol has been rationalized to offer a distinct advantage (8) .
In this laboratory, we have been interested in investigating the mode of action of progesterone, with a particular reference to the modulation of steroid hormone action by progesterone receptor 
MATERIALS AND METHODS
Chemicals: All reagents were of analytical grade and prepared in deionized water unless otherwise noted. Activated charcoal, HEPES and Tris were purchased from Sigma Chemical Company, (St. Louis, MO). Dextran T-70 was purchased from Pharmacia (Uppsala, Sweden). Taxol was purchased from Bio-Synthesis, Inc., Lewisville, TX and cisplatin was received from Johnson Matthey, Westchester, PA.
Cell Culture: T47D wild type cells were obtained from the American Type Culture Collection. These cells were routinely grown in monolayer in the absence of phenol red, and in the presence of 5% CO2, RPMI 1640 with L-glutamine (Sigma), 5 % FBS (Sigma), 25 mM HEPES, 24 mM sodium bicarbonate, 0.5% 100x non-essential amino acid solution (Sigma), 100 units/ml penicillin (Sigma), 0.1 mg/ml streptomycin (Sigma), 0.25 pg/ml amphotericin B, and 0.14 IU/ml insulin at 37°C. The cells were also grown in the above medium containing charcoal-treated 5% FBS.
Cell Proliferation: All the growth studies were conducted in 24-well growth plates. Initially, each well was seeded with 3 X 104 cells in whole serum or 5% Dextran-coated charcoal (DCC)-treated FBS-containing media. The compounds were added 48 h later (day 1) with no medium change in between. Control flasks received only the vehicle. The medium prepared in the absence or presence of the above compounds was changed every 48 h. The quantitation of the cell number was performed each day or as indicated in the figure legends (14) . 
RESULTS AND DISCUSSION
The data in Effect of taxol on the extent of proliferation of T47D cells. Cells were plated in triplicates in 24 well growth plates (15,000 cells/well) containing 5 % whole serum or DCCtreated FBS medium (inset). Two days after plating, the medium was replaced with the same but containing taxol (1 pM) dissolved in methanol (F.C.<0.l%). The medium was changed every 2 days. Triplicate wells were counted for cell number after 8 days and the means were plotted. Fig. 3 . Effects of different concentrations of taxol on the extent of proliferation of T47D cells. Cells were plated in triplicate in 24-well growth plates containing 5% whole FBS medium (15,000 cells/well) or 5% DCC-treated FBS medium (45,000 cell/well) (inset). Two days after plating, the medium was replaced with the same but containing taxol (0.05 -1 pM) dissolved in methanol (final concentration (F.C.) <0.1%). The medium was changed every 2 days. Triplicate wells were counted for cell number after 8 days and the means were plotted. medium (Fig. 3, inset) . In order to examine the influence of taxol on the rate of proliferation, the cell growth was monitored over a 6-8 day period in the presence of 100 nM and 1 pM taxol. in the presence of DCC FBS suggesting that some small molecular weight components of the serum may directly or indirectly enhance cisplatin effectiveness. The effects of cisplatin, in some manner were similar to those upon taxol treatment since the number of cells remaining fell below Cells were plated in triplicates in 24 well growth plates (15,000 cell/well) containing 5% whole FBS medium or 5% DCC-treated FBS medium (inset). Two days after plating, the medium was replaced with the same but containing cisplatin (10 nM) dissolved in saline (F.C. <0.1%). The medium was changed every 2 days. Triplicate wells were counted for cell number every 2 days and the means were plotted. Fig. 6 . Effect of cisplatin and taxol on the rate of proliferation of T47D cells. Cells were plated in triplicate in 24-well growth plates containing 5% whole FBS medium (15,000 cell/well). Two days after plating, the medium was replaced with the same but containing taxol (10 nM) dissolved in methanol (F.C. <0.1%), cisplatin (1 nM) dissolved in saline (F.C. <0.1%) or both. The medium was changed every 2 days. Triplicate wells were counted for cell number every 2 days and the means were plotted.
the original level. It is thus possible that the observed cisplatin effects are due to the phenomenon of apoptosis (7) Although the observed effects of both of these compounds are rather steep even at lower concentrations, we were able to observe a further, albeit, modest inhibition in the rate of cell growth. Future analysis on these aspects may reveal more drastic additive effects of the two compounds at much lower concentrations.
We have presented evidence that taxol and cisplatin exert strong inhibitory influence on the proliferation of T47D cells. Taxol is known to block cellular proliferation by a novel mechanism that involves promotion and stabilization of the assembly of microtubules and inhibit depolymerization. The above processes block reorganization of microtubules causing interruption of cell division. A number of clinical studies have established the antitumor activity of taxol in the management of advanced ovarian and lung cancers (15, 16) . Clinical trials of taxol as an active drug in the treatment of metastatic breast cancer have also been encouraging (17) . In recent years, combination chemotherapeutic trials with taxol and cisplatin have been undertaken (7, 18) . It has been shown that cytotoxicity that results from the combination of taxol and cisplatin is greatly increased when compared with effects of the two agents administered separately (8) . Taxol appears to be twice as cytotoxic as cisplatin (19) and has also been reported to exert antineoplastic actions in patients with platinum-resistant ovarian cancer (20) .
These and other reports still leave much information to be desired about the dose response and Taxol has been shown to be taken up well by MCF-7 cells, an estrogen-dependent cancer cell line where it has been observed to reduce the percentage of cells in S-phase (24) . Clearly, the effects of steroids, and taxol and cisplatin appear to be independent but these can be monitored conveniently in T47D cells. The results of our study present a good model system to study indepth the influence of these and other cytotoxic and chemotherapeutic drugs and to optimize conditions of their effective use.
